Skip to main content

Animations

MJFF Publications

4931 - 4940 of 8808 Results
Title
Year
  • Year
  • 2023
  • 2025
  • 2023
  • 2023
  • 2024
  • 2025
  • 2024
  • 2024
  • 2025
  • 2025
  • Summary Details
    OPEN
    Title: DOPA pheomelanin is increased in nigral neuromelanin of Parkinson’s disease
    Journal Name: Progress in Neurobiology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.pneurobio.2023.102414
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Advice for translational neuroscience: move deliberately and build things
    Journal Name: Bioelectronic Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s42234-025-00165-w
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Genetics of Parkinson's disease heterogeneity: A genome-wide association study of clinical subtypes
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105935
    Citation Count: 6
  • Summary Details
    RESTRICTED
    Title: Examining the association between posttraumatic stress disorder and disruptions in cortical networks identified using data-driven methods
    Journal Name: Neuropsychopharmacology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s41386-023-01763-5
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Mouse α-synuclein fibrils are structurally and functionally distinct from human fibrils associated with Lewy body diseases
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/sciadv.adq3539
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Global cellular proteo-lipidomic profiling of diverse lysosomal storage disease mutants using nMOST
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/sciadv.adu5787
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Psychotropic medication usage in sporadic versus genetic behavioral‐variant frontotemporal dementia
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/alz.14448
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Sex‐specific mechanisms of cerebral microvascular BKCa dysfunction in a mouse model of Alzheimer's disease
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/alz.14438
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Evidence for alpha-synuclein aggregation in older individuals with hyposmia: a cross-sectional study
    Journal Name: eBioMedicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.ebiom.2025.105567
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Baseline liver fibrosis-4 score correlates to the progression of anxiety and cognitive impairment in patients with Parkinson’s disease
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2025.1501319
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.